Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen Study highlights need for defined markers of mpox immunity to inform public health use.

https://www.nih.gov/news-events/news-releases/lower-dose-mpox-vaccine-safe-generates-six-week-antibody-response-equivalent-standard-regimen